跳至主要内容
临床试验/IRCT2014120220184N1
IRCT2014120220184N1已完成早期 1 期

Investigation of the Effectiveness of L-Lysine Supplementation in the Control of Fasting Blood Sugar in Type 2 Diabetic Patients.

Iran National Science Foundation (INSF)0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
早期 1 期
状态
已完成
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
41 years 至 75 years(—)
性别
All

入选标准

  • Inclusion Criteria: Glycated hemoglobin (HbA1c) = 7%; normal serum insulin level; no history of ketoacidosis, cancer, hyper- or hypothyroidism, diabetic ulcer, chronic renal failure, liver cirrhosis, feverish diseases and consumption of corticosteroids; with serum creatinine = 2 mg/dl; no symptom of hypoinsulinemia such as ketonuria, weight loss; serum glucose level more than 400 mg/dl.

排除标准

  • no response to oral agents; need for insulin therapy; appearance of diabetic ulcer or feverish diseases during treatment.

研究者

发起方
Iran National Science Foundation (INSF)

相似试验